NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CellFE

CellFE

Private
Alameda, CaliforniaHealthcare & Life Scienceshttps://www.cellfebiotech.com/

Last Round

Series A

Sep 27, 2023

Total Funding Raised

$26.8M

Company Overview

CellFE is a biotechnology company that develops a microfluidic-based intracellular gene delivery platform for transporting gene-editing molecules into human cells to enhance cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

cell therapy manufacturingmicrofluidicsnon-viral gene deliverymechanoporationCAR-T therapycellular engineeringbioprocessinggene editinglife science toolscell engineering platformtransfectionbenchtop instrumentationbiotech hardwarerazor-and-blade modelcell therapy scale-up

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CellFE Comparables

Compare CellFE with similar companies based on industry and business-model similarity.

CellFE comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Indee Labs
87%
Portal Biotechnologies
86%
Avectas
85%

CellFE Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 27, 2023
SeedMar 31, 2020
GrantAug 27, 2019

Key People

Founding team and executive leadership

Todd Sulchek

Chief Scientific Officer, Co-Founder

Founding Team

Alla Zamarayeva

Co-founder And CEO

Founding Team

CellFE Investors

Notable investors and investment history

CellFE investors
InvestorRounds
GreatPoint VenturesSeries A
Cota CapitalSeries A, Seed
Dynamk CapitalSeries A, Seed
Khosla VenturesSeries A
Embark VenturesSeed, Series A
M VenturesSeries A
Elm Street VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 30, 2025

    Collaborating with Tcelltech GmbH to advance cell therapy development.

  • Jan 22, 2025

    Launched CellFE T-Rest, a transfection media for resting T cell workflows.

CellFE Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CellFE Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CellFE's valuation, stock price, and market status.

Firmographic Details

HeadquartersAlameda, California
Employee Range20
Year Founded2018
Last FundingSep 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.